Drug and Therapeutics Bulletin 1998;36:77-79; doi:10.1136/dtb.1998.361077
Copyright © 1998 by the BMJ Publishing Group Ltd.
Update on drugs for herpes zoster and genital herpes
We reviewed the use of aciclovir (Zovirax - Glaxo Wellcome) 6 years ago.1 Since then, two more oral antiherpetic drugs have been licensed - famciclovir (Famvir - SmithKline Beecham) and valaciclovir (Valtrex - Glaxo Wellcome). Here we discuss their efficacy and safety, and review their place in the management of patients with herpes zoster (shingles) and genital herpes, comparing them with aciclovir.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Infections
-
Obstetrics, gynaecology and fertility
-
Urinary and genital tract disorders
-
Infectious diseases
- Sexual Health
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
